EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Efficacy of combined low-molecular-weight heparin and low-dose aspirin therapy versus aspirin alone in women with thrombophilia-related recurrent pregnancy loss: A retrospective cohort study

Hyun Mi Kim, Won-Kyu Jang, Jisun Lee, Dong Ja Kim, Joon Cheol Park

Journal of Reproductive Immunology · 2026-08 · 176 · 104922

DOI: 10.1016/j.jri.2026.104922 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Reproductive Immunology, 2026-08. Verfasst von Hyun Mi Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Obstetrics and Gynecolo…. Hauptthemen laut MEDLINE: Aspirin, Abortion, Habitual, Heparin, Low-Molecular-Weight, Thrombophilia. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of inherited thrombophilia (IT) in recurrent pregnancy loss (RPL) remains uncertain, unlike established antiphospholipid antibodies (APA). This study evaluated pregnancy outcomes in APA and IT patients, comparing low-molecular-weight heparin (LMWH) plus low-dose aspirin (LDA) versus LDA alone in IT. After excluding genetic, anatomical, and endocrinologic causes, 227 women with RPL related to APA or IT such as protein C, protein S, and antithrombin III deficiencies, factor V Leiden, or prothrombin gene mutations were enrolled. All women with thrombotic causes were taking LDA before pregnancy. LMWH was added after a positive pregnancy test in women with APA, and women with IT received either LMWH plus LDA or LDA alone. Pregnancy outcomes and miscarriage rates were compared by etiology and treatment. The APA group had significantly higher miscarriage rates than IT group (30.4% vs. 14.8%, p = 0.024) despite LMWH + LDA treatment. Within the IT group (106 LDA-only, 54 LMWH+LDA), miscarriage and full-term birth rates were similar, but early preterm birth < 34 weeks was significantly lower with LMWH + LDA treatment (p = 0.045). Women with APA-related RPL had worse outcomes than IT patients despite LMWH and LDA treatment. In IT-associated RPL, adding LMWH to LDA may not prevent miscarriage but could reduce early preterm birth risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinAbortion, HabitualHeparin, Low-Molecular-WeightThrombophiliaHumansFemalePregnancyAdultRetrospective StudiesDrug Therapy, CombinationPregnancy OutcomeAntibodies, AntiphospholipidTreatment Outcome

Stichwörter der Autor:innen

Antiphospholipid antibodiesMiscarriageRecurrent pregnancy lossThrombophilia

Substanzen

AspirinHeparin, Low-Molecular-WeightAntibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Obstetrics and Gynecology, Kyungpook National University hospital, Daegu, South Korea.
  • Department of Forensic Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, South Korea.
  • Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Obstetrics and Gynecology, Kyungpook National University hospital, Daegu, South Korea. Electr…

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Kim, H. M., Jang, W. K., Lee, J., Kim, D. J., & Park, J. C. (2026). Efficacy of combined low-molecular-weight heparin and low-dose aspirin therapy versus aspirin alone in women with thrombophilia-related recurrent pregnancy loss: A retrospective cohort study. Journal of Reproductive Immunology, 176, 104922. https://doi.org/10.1016/j.jri.2026.104922

Vancouver

Kim HM, Jang WK, Lee J, Kim DJ, Park JC. Efficacy of combined low-molecular-weight heparin and low-dose aspirin therapy versus aspirin alone in women with thrombophilia-related recurrent pregnancy loss: A retrospective cohort study. Journal of Reproductive Immunology. 2026;176:104922. doi:10.1016/j.jri.2026.104922

BibTeX
@article{Kim2026,
  author = {Kim, Hyun Mi and Jang, Won-Kyu and Lee, Jisun and Kim, Dong Ja and Park, Joon Cheol},
  title = {Efficacy of combined low-molecular-weight heparin and low-dose aspirin therapy versus aspirin alone in women with thrombophilia-related recurrent pregnancy loss: A retrospective cohort study},
  journal = {Journal of Reproductive Immunology},
  year = {2026},
  volume = {176},
  pages = {104922},
  doi = {10.1016/j.jri.2026.104922}
}
Kostenlos starten →